Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-022908
Filing Date
2016-06-15
Accepted
2016-06-15 13:43:28
Documents
2
Period of Report
2016-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1554
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 5092
  Complete submission text file 0000899243-16-022908.txt   7962
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Freed Martin I (Reporting) CIK: 0001676653 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36281 | Film No.: 161714921